Fostera PCV: Flexible dosing to prevent PCV2 viremia

22-05-2012 | | |
Fostera PCV: Flexible dosing to prevent PCV2 viremia

Now offering a high standard in protocol flexibility, Fostera PCV is the only PCV vaccine that can be incorporated into vaccination programs using either two doses or one to help prevent Porcine Circovirus Type 2 (PCV2) viremia and help control lymphoid depletion.


Any amount of PCV2 viremia may negatively impact production, so the goal of vaccination is to create an environment with the least amount of virus present. A study demonstrated that vaccination of pigs with two doses of Fostera PCV compared to non-vaccinated pigs helped prevent PCV2 viremia and helped provide protection against PCV2 infection in lymphatic tissues:
  • Reduced viremia by up to 8,000 times post-challenge, resulting in a total of 96.8 percent viremia-free days while in study
  • All lymphatic tissues in vaccinated pigs were negative for PCV2 infection
“Whether you decide to administer two doses or one of Fostera PCV, both options effectively offer a high standard of consistent performance to help protect pigs against this performance-robbing disease,” says Darrell Neuberger, DVM, pork technical services veterinarian for Pfizer Animal Health.
Fostera PCV, which will have a new look featuring a large PCV mark in the upcoming months, can be administered in two ways:
  • Two 1-mL doses 3 weeks apart starting at 3 weeks of age or older
  • One 2-mL dose at 3 weeks of age or older
More about